Your browser is no longer supported. Please, upgrade your browser.
CERC Cerecor Inc. monthly Stock Chart
CERC [NASD]
Cerecor Inc.
Index- P/E6.94 EPS (ttm)0.59 Insider Own1.50% Shs Outstand32.33M Perf Week-11.55%
Market Cap131.26M Forward P/E- EPS next Y- Insider Trans- Shs Float19.31M Perf Month-7.31%
Income12.10M PEG- EPS next Q- Inst Own53.70% Short Float1.19% Perf Quarter8.85%
Sales31.90M P/S4.11 EPS this Y140.20% Inst Trans0.07% Short Ratio3.08 Perf Half Y2.78%
Book/sh0.78 P/B5.21 EPS next Y- ROA33.30% Target Price1.00 Perf Year600.00%
Cash/sh0.08 P/C52.50 EPS next 5Y- ROE61.10% 52W Range0.52 - 5.74 Perf YTD26.87%
Dividend- P/FCF10.50 EPS past 5Y21.20% ROI50.60% 52W High-29.26% Beta-
Dividend %- Quick Ratio0.70 Sales past 5Y220.10% Gross Margin95.30% 52W Low675.10% ATR0.28
Employees38 Current Ratio0.90 Sales Q/Q1066.80% Oper. Margin43.50% RSI (14)39.93 Volatility8.47% 6.50%
OptionableYes Debt/Eq0.63 EPS Q/Q35.40% Profit Margin37.20% Rel Volume0.35 Prev Close4.03
ShortableYes LT Debt/Eq0.59 EarningsAug 13 BMO Payout0.00% Avg Volume74.42K Price4.06
Recom2.00 SMA20-8.82% SMA50-9.96% SMA20013.29% Volume26,657 Change0.74%
Dec-12-16Downgrade Rodman & Renshaw Buy → Neutral $4 → $1
Apr-13-16Initiated Rodman & Renshaw Buy $15
Dec-09-15Initiated Laidlaw Buy $10
Aug-15-18 01:15PM  CERC: Phase 1 Trial of CERC-301 in nOH Underway Zacks Small Cap Research
Aug-09-18 06:30AM  Cerecor Reports Second Quarter 2018 Financial Results GlobeNewswire -7.63%
Aug-01-18 06:30AM  Cerecor Announces First Patient Enrolled in Phase I Trial for Neurogenic Orthostatic Hypotension (nOH) in Parkinsons Disease GlobeNewswire
Jul-31-18 01:37PM  Penny Stocks to Watch for August 2018 Investopedia
Jul-16-18 06:00AM  Cerecor Announces Expansion of Leadership Team GlobeNewswire
Jul-12-18 02:00AM  [$$] The drug pricing playbook: how pharma companies keep costs high Financial Times
May-22-18 08:29AM  BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board GlobeNewswire
May-19-18 10:02AM  May Top Undervalued Stock Simply Wall St.
May-17-18 09:55AM  CERC: Converting into a Fully Independent Healthcare Company Zacks Small Cap Research
08:01AM  BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business GlobeNewswire
May-11-18 08:15AM  Cerecor Reports First Quarter 2018 Financial Results GlobeNewswire -10.03%
May-10-18 07:40AM  Wired News CymaBay Therapeutics Starts Phase-2b Clinical Trials of Seladelpar for Treatment of Patients with Non-Alcoholic Steatohepatitis ACCESSWIRE
Apr-09-18 08:00AM  Cerecor Appoints Simon Pedder to its Board of Directors Marketwired -5.31%
Apr-02-18 08:00AM  Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2017 Marketwired
Mar-28-18 10:02AM  Flavor Of The Month: inTEST And More Simply Wall St. -7.78%
08:00AM  Cerecor Appoints Peter Greenleaf as Chief Executive Officer Marketwired
Mar-07-18 03:15PM  Have Investors Already Priced In Cerecor Incs (NASDAQ:CERC) Growth? Simply Wall St. +9.90%
Feb-12-18 05:06PM  Cerecor Incs (NASDAQ:CERC) Insiders Recently Ramped Up Their Holdings Should You? Simply Wall St. +9.84%
09:07AM  Cerecor to Acquire Avadel Pharmaceuticals' Pediatric Assets Marketwired
Jan-10-18 07:52PM  What Does Cerecor Incs (NASDAQ:CERC) Ownership Structure Look Like? Simply Wall St. -11.46%
Dec-26-17 09:00AM  Cerecor, Inc. :CERC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017 Capital Cube +9.57%
Dec-25-17 05:45PM  What Are The Drivers Of Cerecor Incs (NASDAQ:CERC) Risks? Simply Wall St.
Dec-18-17 09:05AM  Can Cerecor Inc (NASDAQ:CERC) Continue To Outperform Its Industry? Simply Wall St. +11.86%
Dec-08-17 10:33AM  Should You Buy Cerecor Inc (CERC) At This PE Ratio? Simply Wall St.
Nov-29-17 07:30AM  This Unknown Cannabis Stock Could Have Big Upside as Wall Street Takes Notice ACCESSWIRE +36.36%
Nov-21-17 07:40AM  Corporate News Blog - Cerecor Acquired TRx Pharmaceuticals ACCESSWIRE
Nov-20-17 12:45PM  Is It The Right Time To Buy Cerecor Inc (CERC)? Simply Wall St.
Nov-17-17 10:35AM  Baltimore pharmaceutical company acquiring North Carolina firm for at least $27 million American City Business Journals
08:30AM  Cerecor Announces Leadership Changes Marketwired
08:15AM  Cerecor Acquires TRx Pharmaceuticals Marketwired
08:02AM  Best Undervalued Stock Picks Simply Wall St.
Nov-09-17 11:45AM  CERC: With An Infusion of Non-dilutive Capital, Cerecor Ready to Move the Pipeline Forward Zacks Small Cap Research
Nov-06-17 09:32AM  What does Cerecor Incs (CERC) Balance Sheet Tell Us Abouts Its Future? Simply Wall St.
08:15AM  Cerecor Inc. Reports Third Quarter 2017 Financial Results Marketwired
Oct-18-17 08:15AM  Cerecor, Inc. Regains Compliance with NASDAQ Minimum Bid Price Requirement Marketwired
Oct-05-17 05:46PM  Dilution Ahead For Cerecor Inc (CERC) Shareholders? Simply Wall St.
Aug-17-17 11:15AM  CERC: Sells CERC-501 for $25 Million; Company Currently Trading Below Cash Value Zacks Small Cap Research
Aug-16-17 01:22PM  What Shareholders Should Make of the Johnson & Johnson-Cerecor Situation GuruFocus.com
10:44AM  Cerecor, Inc. :CERC-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube
Aug-14-17 08:04AM  Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer Marketwired
08:02AM  Cerecor Inc. Reports Second Quarter 2017 Financial Results Marketwired
08:00AM  Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc. Marketwired
May-30-17 08:30AM  Cerecor to present at the American Society for Clinical Psychopharmacology Conference Marketwired -10.71%
May-15-17 08:30AM  Cerecor Appoints Steven Boyd and Peter Greenleaf to Board of Directors Marketwired
May-10-17 02:00PM  CERC: Encouraging Results from Proof-of-Concept Study of CERC-501 in MDD Zacks Small Cap Research -6.09%
May-09-17 08:30AM  Cerecor Inc. Reports First Quarter 2017 Financial Results Marketwired +13.87%
May-01-17 08:30AM  Cerecor Reports Encouraging Topline Data from a NIH Sponsored Proof-of-Concept Trial of CERC-501 in Treatment-Resistant Depression Marketwired +20.50%
Apr-28-17 08:30AM  Cerecor Inc. Closes $5.0 Million Private Placement Marketwired -16.57%
Mar-21-17 03:00PM  CERC: Ready to Move Ahead With Phase 2/3 Study of CERC-501 in MDD Zacks Small Cap Research -8.11%
Mar-18-17 01:04PM  CERECOR INC. Financials
Mar-14-17 01:22PM  CERECOR INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -10.00%
09:37AM  Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 Marketwired
Mar-13-17 05:25PM  CERECOR INC. Files SEC form 8-K, Change in Directors or Principal Officers -24.99%
Mar-02-17 04:39PM  CERECOR INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
Feb-16-17 01:34PM  These 5 Stocks Under $10 Could Explode Higher
Feb-07-17 09:32AM  Cerecor Engages SunTrust Robinson Humphrey to Assist with Review of Strategic Alternatives Marketwired
Jan-30-17 04:34PM  CERECOR INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -6.52%
Jan-27-17 04:26PM  CERECOR INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits +5.75%
04:20PM  Cerecor Announces At-the-Market Equity Offering Program Marketwired
Jan-20-17 04:05PM  CERECOR INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
Dec-12-16 07:12AM  Cerecor downgraded by Rodman & Renshaw
Dec-06-16 04:09PM  Cerecor Nicotine Withdrawal Drug Fails Study (CERC) Investopedia -15.79%
04:09PM  Cerecor Nicotine Withdrawal Drug Fails Study (CERC) at Investopedia
01:06PM  Cerecor Inc (CERC)s Trial Failure Isnt All Bad, Heres The Silver Lining Insider Monkey
01:06PM  Cerecor Inc (CERC)s Trial Failure Isnt All Bad, Heres The Silver Lining at Insider Monkey
Dec-05-16 03:00PM  CERC: CERC-501 Not Successful in Nicotine Withdrawal; Preparing for Phase 2/3 Study of CERC-501 in MDD Zacks Small Cap Research -13.14%
11:51AM  Ciao, euro! Global markets gird for the next wave of global populism at MarketWatch
08:16AM  CERECOR INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:14AM  Cerecor Inc. shares drop 37% after midstage trial failure at MarketWatch
08:00AM  Cerecor Announces Top-Line Results from CERC-501 Phase 2 Study for Nicotine Withdrawal Marketwired
Dec-01-16 12:45PM  Cerecor Depression Drug Fails Phase 2 Trial (CERC) Investopedia
12:45PM  Cerecor Depression Drug Fails Phase 2 Trial (CERC) at Investopedia
Nov-30-16 12:30PM  CERC: CERC-301 Fails to Show Benefit in MDD in Phase 2 Clinical Trial; Attention Now Turns to CERC-501 -55.93%
Nov-29-16 04:10PM  CERECOR INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -7.63%
04:01PM  Cerecor Reports Top-Line Data from CERC-301 Phase 2 Study for Major Depressive Disorder Marketwired
Nov-11-16 01:00PM  CERC: Results from Phase 2 Study of CERC-301 in Major Depressive Disorder to be Announced in November 2016
Nov-08-16 10:53AM  CERECOR INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
09:16AM  Cerecor Inc. Reports Third Quarter 2016 Financial Results Marketwired
Nov-07-16 02:35PM  Discovery of Cerecor Drug Candidate CERC-611 (LY3130481) Published in Nature Medicine Marketwired +9.94%
Oct-24-16 09:59AM  What To Watch From The Upcoming Cerecor Inc (CERC) Release at Insider Monkey
Oct-21-16 08:30AM  Why Traders Are Buzzing About Qualcomm, NXP, Alkermes, Cerecor, and More at Insider Monkey +22.09%
Oct-10-16 09:10AM  Cerecor to Present at the 15th Annual BIO Investor Forum in San Francisco on October 18th, 2016 Business Wire
Sep-29-16 11:00AM  CERC: Acquires Rights to Anti-Epilepsy Drug
Sep-26-16 04:19PM  CERECOR INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
09:10AM  Cerecor Announces Acquisition of TARP-8-AMPA Receptor Antagonist (CERC-611) from Lilly Business Wire
Sep-22-16 12:00PM  CERC: Multiple Catalysts Upcoming in 4Q16
Sep-21-16 02:23PM  CERECOR INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits +8.47%
09:10AM  Cerecor Announces Completion of Enrollment in Phase 2 Clinical Trial with CERC-301 as an Oral, Adjunctive Treatment of Major Depressive Disorder Business Wire
Sep-12-16 09:35AM  CERECOR INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities,
09:10AM  Cerecor Enters Into a $15 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC Business Wire
Sep-06-16 10:57AM  CERECOR INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
09:10AM  Cerecor Announces Last Patient Enrolled in Phase 2 Clinical Trial with CERC-501 for Smoking Cessation Business Wire
Sep-01-16 09:10AM  Cerecor to Present at 23rd Annual NewsMakers in the Biotech Industry Conference in New York City, September 9, 2016 Business Wire
Aug-29-16 10:46AM  CERECOR INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
09:10AM  Cerecor Inc. Announces Initiation of Second CERC-501 Phase 2 Clinical Trial in Smokers Business Wire
Aug-23-16 03:30PM  CERC: Results From Phase 2 Clinical Trial of CERC-501 to be Reported in 4Q16
Aug-22-16 09:10AM  Cerecor to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016 Business Wire
Aug-15-16 09:59AM  CERECOR INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
09:10AM  Cerecor Inc. Reports Second Quarter 2016 Financial Results Business Wire
Jul-29-16 09:28AM  These 5 Stocks Are Poised for Breakouts
Cerecor Inc., a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation. It also offers Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension; and Flexichamber. The company is developing CERC-301, an orphan neurological indication for controlling neurologic adaptation; CERC-611, a drug candidate for the treatment of partial-onset seizures in epilepsy; and two preclinical stage development candidates, CERC-406 and CERC-425 potential for the treatment of motoric and non-motoric symptoms of Parkinson's disease, as well as other psychiatric and neurological conditions. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Baltimore, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARMISTICE CAPITAL, LLCDirectorJul 31Buy4.216552,75716,480,000Aug 01 05:04 PM
ARMISTICE CAPITAL, LLCDirectorJul 30Buy4.262,2009,37716,479,345Aug 01 05:04 PM
ARMISTICE CAPITAL, LLCDirectorJul 27Buy4.4317,14575,87116,477,145Jul 27 05:25 PM
ARMISTICE CAPITAL, LLCDirectorJul 26Buy4.484,08118,30116,460,000Jul 27 05:25 PM
ARMISTICE CAPITAL, LLCDirectorJul 25Buy4.347,70033,40416,455,919Jul 27 05:25 PM
ARMISTICE CAPITAL, LLCDirectorJul 18Buy4.352,50010,86616,448,219Jul 18 05:24 PM
ARMISTICE CAPITAL, LLCDirectorJul 17Buy4.309,71941,77416,445,719Jul 18 05:24 PM
ARMISTICE CAPITAL, LLCDirectorJul 16Buy4.2617,80075,76516,436,000Jul 18 05:24 PM
ARMISTICE CAPITAL, LLCDirectorJul 02Buy4.283,80016,27616,418,200Jul 02 05:54 PM
ARMISTICE CAPITAL, LLCDirectorJun 28Buy4.0614,40058,48216,414,400Jul 02 05:54 PM
ARMISTICE CAPITAL, LLCDirectorMay 23Buy3.853001,15516,400,000May 23 05:54 PM
ARMISTICE CAPITAL, LLCDirectorMay 22Buy3.857,54129,02116,399,700May 23 05:54 PM
ARMISTICE CAPITAL, LLCDirectorMay 21Buy3.7742,159158,99816,392,159May 23 05:54 PM
Greenleaf PeterChief Executive OfficerMay 18Buy3.9812,50049,750412,500May 21 07:10 PM
ARMISTICE CAPITAL, LLCDirectorMay 17Buy3.8327,700106,12416,350,000May 17 05:31 PM
ARMISTICE CAPITAL, LLCDirectorMay 16Buy3.759,60035,97516,322,300May 17 05:31 PM
ARMISTICE CAPITAL, LLCDirectorMay 15Buy3.5192,700325,53516,312,700May 17 05:31 PM
ARMISTICE CAPITAL, LLCDirectorApr 23Buy4.176,18925,79516,220,000Apr 23 06:56 PM
ARMISTICE CAPITAL, LLCDirectorApr 20Buy3.596002,15616,213,811Apr 23 06:56 PM
ARMISTICE CAPITAL, LLCDirectorApr 19Buy3.5713,21147,19516,213,211Apr 23 06:56 PM
ARMISTICE CAPITAL, LLCDirectorApr 18Buy3.4181,544278,39116,200,000Apr 18 05:38 PM
ARMISTICE CAPITAL, LLCDirectorApr 17Buy3.5127,36096,09716,118,456Apr 18 05:38 PM
ARMISTICE CAPITAL, LLCDirectorApr 16Buy3.3641,096137,88516,091,096Apr 18 05:38 PM
Moscato Robert Jr.COODec 04Buy1.772855042,592,743Dec 07 07:15 PM
ARMISTICE CAPITAL, LLCDirectorNov 24Buy1.2010,00011,98016,050,000Nov 24 03:20 PM
ARMISTICE CAPITAL, LLCDirectorNov 22Buy1.2035,20042,21016,040,000Nov 24 03:20 PM
ARMISTICE CAPITAL, LLCDirectorOct 16Buy1.084,8005,17416,004,800Oct 18 05:12 PM
ARMISTICE CAPITAL, LLCDirectorSep 29Buy0.876,8835,98616,000,000Oct 03 06:02 PM
ARMISTICE CAPITAL, LLCDirectorSep 28Buy0.8430025115,993,117Sep 28 05:53 PM
ARMISTICE CAPITAL, LLCDirectorSep 27Buy0.811008115,992,817Sep 28 05:53 PM
ARMISTICE CAPITAL, LLCDirectorSep 26Buy0.8013,55210,77415,992,717Sep 28 05:53 PM
ARMISTICE CAPITAL, LLCDirectorSep 22Buy0.7812,3009,64115,979,165Sep 25 05:27 PM
ARMISTICE CAPITAL, LLCDirectorSep 21Buy0.792,3601,85315,966,865Sep 25 05:27 PM
ARMISTICE CAPITAL, LLCDirectorSep 20Buy0.7615,25011,61015,964,505Sep 20 05:35 PM
ARMISTICE CAPITAL, LLCDirectorSep 19Buy0.7430,11922,42915,949,255Sep 20 05:35 PM
ARMISTICE CAPITAL, LLCDirectorSep 18Buy0.786,0004,66715,919,136Sep 20 05:35 PM
ARMISTICE CAPITAL, LLCDirectorSep 08Buy0.752,0601,55115,913,136Sep 08 05:26 PM
ARMISTICE CAPITAL, LLCDirectorSep 06Buy0.742,2391,64715,911,076Sep 08 05:26 PM
ARMISTICE CAPITAL, LLCDirectorSep 01Buy0.7313,86710,18815,908,837Sep 01 05:18 PM
ARMISTICE CAPITAL, LLCDirectorAug 31Buy0.7725,10019,31215,894,970Sep 01 05:18 PM
ARMISTICE CAPITAL, LLCDirectorAug 30Buy0.7451237715,869,870Sep 01 05:18 PM
ARMISTICE CAPITAL, LLCDirectorAug 29Buy0.7250,00035,79515,869,358Aug 29 06:04 PM
ARMISTICE CAPITAL, LLCDirectorAug 28Buy0.7325,32118,37515,819,358Aug 29 06:04 PM
ARMISTICE CAPITAL, LLCDirectorAug 25Buy0.7538,32828,89215,794,037Aug 29 06:04 PM
ARMISTICE CAPITAL, LLCDirectorAug 24Buy0.7039,88827,88615,755,709Aug 24 05:57 PM
ARMISTICE CAPITAL, LLCDirectorAug 24Buy0.7019,94413,94315,755,709Aug 24 05:57 PM
ARMISTICE CAPITAL, LLCDirectorAug 23Buy0.621,8001,11315,735,765Aug 24 05:57 PM
ARMISTICE CAPITAL, LLCDirectorAug 23Buy0.6290055715,735,765Aug 24 05:57 PM
ARMISTICE CAPITAL, LLCDirectorAug 22Buy0.6238,60223,79015,734,865Aug 24 05:57 PM
ARMISTICE CAPITAL, LLCDirectorAug 22Buy0.6219,30111,89515,734,865Aug 24 05:57 PM
ARMISTICE CAPITAL, LLCDirectorAug 21Buy0.6131,12819,06915,715,564Aug 21 06:02 PM
ARMISTICE CAPITAL, LLCDirectorAug 21Buy0.6115,5649,53515,715,564Aug 21 06:02 PM
ARMISTICE CAPITAL, LLCDirectorAug 18Buy0.6163,39638,61515,700,000Aug 21 06:02 PM
ARMISTICE CAPITAL, LLCDirectorAug 18Buy0.6131,69819,30715,700,000Aug 21 06:02 PM
ARMISTICE CAPITAL, LLCDirectorAug 17Buy0.5952,00430,49015,668,302Aug 21 06:02 PM
ARMISTICE CAPITAL, LLCDirectorAug 17Buy0.5926,00215,24515,668,302Aug 21 06:02 PM